annual operating profit:
$97.57M+$10.25M(+11.74%)Summary
- As of today (July 1, 2025), PCRX annual operating income is $97.57 million, with the most recent change of +$10.25 million (+11.74%) on December 31, 2024.
- During the last 3 years, PCRX annual operating profit has fallen by -$35.26 million (-26.54%).
- PCRX annual operating profit is now -26.54% below its all-time high of $132.84 million, reached on December 31, 2021.
Performance
PCRX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$8.18M-$21.36M(-72.31%)Summary
- As of today (July 1, 2025), PCRX quarterly operating income is $8.18 million, with the most recent change of -$21.36 million (-72.31%) on March 31, 2025.
- Over the past year, PCRX quarterly operating profit has dropped by -$6.94 million (-45.90%).
- PCRX quarterly operating profit is now -81.77% below its all-time high of $44.87 million, reached on December 31, 2021.
Performance
PCRX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$90.64M-$6.94M(-7.11%)Summary
- As of today (July 1, 2025), PCRX TTM operating income is $90.64 million, with the most recent change of -$6.94 million (-7.11%) on March 31, 2025.
- Over the past year, PCRX TTM operating profit has dropped by -$2.79 million (-2.98%).
- PCRX TTM operating profit is now -31.98% below its all-time high of $133.25 million, reached on March 31, 2022.
Performance
PCRX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
PCRX Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | -45.9% | -3.0% |
| 3 y3 years | -26.5% | -62.4% | -32.0% |
| 5 y5 years | +173.2% | -38.9% | +180.0% |
PCRX Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.5% | +37.6% | -75.9% | at low | -18.7% | +55.7% |
| 5 y | 5-year | -26.5% | +173.2% | -81.8% | +242.7% | -32.0% | +180.0% |
| alltime | all time | -26.5% | +283.1% | -81.8% | +139.2% | -32.0% | +245.7% |
PCRX Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.18M(-72.3%) | $90.64M(-7.1%) |
| Dec 2024 | $97.57M(+11.7%) | $29.53M(+34.6%) | $97.57M(-4.3%) |
| Sep 2024 | - | $21.95M(-29.1%) | $102.01M(+0.9%) |
| Jun 2024 | - | $30.98M(+104.9%) | $101.13M(+8.3%) |
| Mar 2024 | - | $15.12M(-55.5%) | $93.42M(+7.0%) |
| Dec 2023 | $87.32M(+23.1%) | $33.97M(+61.2%) | $87.32M(+29.2%) |
| Sep 2023 | - | $21.08M(-9.4%) | $67.60M(-1.0%) |
| Jun 2023 | - | $23.26M(+158.0%) | $68.30M(+17.3%) |
| Mar 2023 | - | $9.02M(-36.7%) | $58.21M(-17.9%) |
| Dec 2022 | $70.93M(-46.6%) | $14.24M(-34.6%) | $70.93M(-30.2%) |
| Sep 2022 | - | $21.78M(+65.3%) | $101.55M(-8.9%) |
| Jun 2022 | - | $13.18M(-39.4%) | $111.44M(-16.4%) |
| Mar 2022 | - | $21.73M(-51.6%) | $133.25M(+0.3%) |
| Dec 2021 | $132.84M(+157.9%) | $44.87M(+41.7%) | $132.84M(+17.0%) |
| Sep 2021 | - | $31.67M(-9.5%) | $113.52M(+13.3%) |
| Jun 2021 | - | $34.99M(+64.2%) | $100.16M(+68.5%) |
| Mar 2021 | - | $21.31M(-16.6%) | $59.44M(+15.4%) |
| Dec 2020 | $51.52M(+44.3%) | $25.55M(+39.5%) | $51.52M(+26.7%) |
| Sep 2020 | - | $18.31M(-419.6%) | $40.65M(+25.6%) |
| Jun 2020 | - | -$5.73M(-142.8%) | $32.37M(-30.8%) |
| Mar 2020 | - | $13.39M(-8.8%) | $46.77M(+31.0%) |
| Dec 2019 | $35.71M(+104.3%) | $14.68M(+46.3%) | $35.71M(+7.1%) |
| Sep 2019 | - | $10.03M(+15.6%) | $33.35M(+16.5%) |
| Jun 2019 | - | $8.68M(+274.0%) | $28.62M(+7.4%) |
| Mar 2019 | - | $2.32M(-81.2%) | $26.65M(+52.5%) |
| Dec 2018 | $17.48M(-187.1%) | $12.31M(+132.1%) | $17.48M(+27.2%) |
| Sep 2018 | - | $5.31M(-20.8%) | $13.74M(+168.3%) |
| Jun 2018 | - | $6.70M(-197.9%) | $5.12M(-139.8%) |
| Mar 2018 | - | -$6.85M(-179.8%) | -$12.87M(-35.9%) |
| Dec 2017 | -$20.07M | $8.58M(-359.0%) | -$20.07M(-35.5%) |
| Sep 2017 | - | -$3.31M(-70.7%) | -$31.11M(-36.1%) |
| Jun 2017 | - | -$11.29M(-19.7%) | -$48.66M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$14.05M(+470.9%) | -$43.82M(+36.8%) |
| Dec 2016 | -$32.02M(-438.7%) | -$2.46M(-88.2%) | -$32.02M(+5.4%) |
| Sep 2016 | - | -$20.86M(+223.8%) | -$30.38M(+590.0%) |
| Jun 2016 | - | -$6.44M(+185.9%) | -$4.40M(-214.0%) |
| Mar 2016 | - | -$2.25M(+177.2%) | $3.86M(-59.2%) |
| Dec 2015 | $9.46M(-283.1%) | -$813.00K(-115.9%) | $9.46M(-48.0%) |
| Sep 2015 | - | $5.11M(+181.0%) | $18.19M(+50.4%) |
| Jun 2015 | - | $1.82M(-45.6%) | $12.09M(+62.7%) |
| Mar 2015 | - | $3.34M(-57.8%) | $7.43M(-243.8%) |
| Dec 2014 | -$5.17M(-90.3%) | $7.92M(-903.9%) | -$5.17M(-77.4%) |
| Sep 2014 | - | -$985.00K(-65.3%) | -$22.90M(-34.1%) |
| Jun 2014 | - | -$2.84M(-69.3%) | -$34.73M(-20.9%) |
| Mar 2014 | - | -$9.26M(-5.7%) | -$43.90M(-17.6%) |
| Dec 2013 | -$53.29M(+8.1%) | -$9.82M(-23.4%) | -$53.29M(-10.1%) |
| Sep 2013 | - | -$12.81M(+6.7%) | -$59.30M(-4.7%) |
| Jun 2013 | - | -$12.01M(-35.6%) | -$62.19M(+9.5%) |
| Mar 2013 | - | -$18.64M(+17.8%) | -$56.81M(+15.2%) |
| Dec 2012 | -$49.30M(+36.6%) | -$15.83M(+0.8%) | -$49.30M(+9.1%) |
| Sep 2012 | - | -$15.71M(+137.0%) | -$45.17M(+18.3%) |
| Jun 2012 | - | -$6.63M(-40.5%) | -$38.19M(-4.8%) |
| Mar 2012 | - | -$11.14M(-4.8%) | -$40.10M(+11.1%) |
| Dec 2011 | -$36.08M(+58.9%) | -$11.70M(+34.0%) | -$36.08M(+18.7%) |
| Sep 2011 | - | -$8.73M(+2.4%) | -$30.40M(+8.1%) |
| Jun 2011 | - | -$8.53M(+19.8%) | -$28.11M(+11.5%) |
| Mar 2011 | - | -$7.12M(+18.5%) | -$25.21M(+11.0%) |
| Dec 2010 | -$22.71M(-20.5%) | -$6.01M(-6.8%) | -$22.70M(-7.3%) |
| Sep 2010 | - | -$6.45M(+14.6%) | -$24.50M(+1.4%) |
| Jun 2010 | - | -$5.63M(+22.0%) | -$24.17M(+30.3%) |
| Mar 2010 | - | -$4.62M(-40.9%) | -$18.55M(+33.1%) |
| Dec 2009 | -$28.55M(-37.1%) | -$7.81M(+27.6%) | -$13.93M(+127.6%) |
| Sep 2009 | - | -$6.12M | -$6.12M |
| Dec 2008 | -$45.36M | - | - |
FAQ
- What is Pacira BioSciences annual operating income?
- What is the all time high annual operating profit for Pacira BioSciences?
- What is Pacira BioSciences annual operating profit year-on-year change?
- What is Pacira BioSciences quarterly operating income?
- What is the all time high quarterly operating profit for Pacira BioSciences?
- What is Pacira BioSciences quarterly operating profit year-on-year change?
- What is Pacira BioSciences TTM operating income?
- What is the all time high TTM operating profit for Pacira BioSciences?
- What is Pacira BioSciences TTM operating profit year-on-year change?
What is Pacira BioSciences annual operating income?
The current annual operating profit of PCRX is $97.57M
What is the all time high annual operating profit for Pacira BioSciences?
Pacira BioSciences all-time high annual operating income is $132.84M
What is Pacira BioSciences annual operating profit year-on-year change?
Over the past year, PCRX annual operating income has changed by +$10.25M (+11.74%)
What is Pacira BioSciences quarterly operating income?
The current quarterly operating profit of PCRX is $8.18M
What is the all time high quarterly operating profit for Pacira BioSciences?
Pacira BioSciences all-time high quarterly operating income is $44.87M
What is Pacira BioSciences quarterly operating profit year-on-year change?
Over the past year, PCRX quarterly operating income has changed by -$6.94M (-45.90%)
What is Pacira BioSciences TTM operating income?
The current TTM operating profit of PCRX is $90.64M
What is the all time high TTM operating profit for Pacira BioSciences?
Pacira BioSciences all-time high TTM operating income is $133.25M
What is Pacira BioSciences TTM operating profit year-on-year change?
Over the past year, PCRX TTM operating income has changed by -$2.79M (-2.98%)